enrasentan has been researched along with Cardiovascular Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cosenzi, A | 1 |
1 review(s) available for enrasentan and Cardiovascular Diseases
| Article | Year |
|---|---|
Enrasentan, an antagonist of endothelin receptors.
Topics: Animals; Carboxylic Acids; Cardiovascular Diseases; Endothelin Receptor Antagonists; Endothelins; Humans; Indans; Receptors, Endothelin | 2003 |